BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $39,149,000 | -7.0% | 760,622 | -33.2% | 0.03% | -15.2% |
| Q4 2018 | $42,116,000 | +21.1% | 1,138,896 | +22.9% | 0.03% | +200.0% |
| Q3 2018 | $34,790,000 | +1363.0% | 926,508 | +1440.0% | 0.01% | +450.0% |
| Q2 2018 | $2,378,000 | +25.2% | 60,162 | -18.4% | 0.00% | +100.0% |
| Q1 2018 | $1,899,000 | +26.0% | 73,719 | +31.9% | 0.00% | 0.0% |
| Q4 2017 | $1,507,000 | -69.0% | 55,871 | -57.0% | 0.00% | -66.7% |
| Q3 2017 | $4,859,000 | +126.5% | 129,998 | +51.5% | 0.00% | +50.0% |
| Q2 2017 | $2,145,000 | – | 85,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |